Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston Children's Hospital
- Study ID
- NCT05899166
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - 12 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ketogenic diet, food delivery and education — OTHERMeals and groceries will be delivered and participants will receive education on nutrition, meal preparation, and diabetes care strategies. Participants will consume study-prescribed foods exclusively.
- Standard diet, food delivery and education — OTHERMeals and groceries will be delivered and participants will receive education on nutrition, meal preparation, and diabetes care strategies. Participants will consume study-prescribed foods exclusively.
Study Details
The goal of this clinical trial is to test the effects of a ketogenic diet on the progression and control of type 1 diabetes in children with newly diagnosed diabetes. The main questions to answer are: * Does a ketogenic diet prolong the honeymoon period of type 1 diabetes? * Does a ketogenic diet improve diabetes control? * Is a ketogenic diet safe, acceptable and sustainable in children with newly diagnosed diabetes? * What are the microbiome, inflammatory and metabolic changes linking diet to β-cell function? Participants will receive a combination of free meals, groceries, micronutrient supplements, and intensive diet and diabetes education for 9 months. * Diabetes care devices will be connected for cloud-based data collection. * Bi-weekly data downloads and remote check-ins will assess dietary intake, satisfaction with diet and study procedures, and possible safety concerns. * During four study visits held at at baseline, 1, 5, and 9 months, an intravenous catheter (IV) will be placed for collection of 5 blood samples before and up to 2 hours after a liquid test meal (protein shake) to assess insulin response. A stool sample will also be collected to assess microbiome changes. * Children and their caregivers may be invited to participate in a semi-structured interview, and online questionnaires to assess their experience with the diet and diabetes care, general well-being and quality of life. * Children and their caregivers may be invited to participate in a follow-up visit to evaluate long-term effects after 24 months. Comparison will be made between a ketogenic vs standard diet.
Key Dates
- Start date
- May 31, 2024
- Status verified
- Apr 2025
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2029
Study Design
- Enrollment
- 52 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ketogenic dietThe diet will be high in protein and healthy fats and comprise meat, fish, fibrous vegetables, nuts, dairy, and berries. Macronutrient composition will be \~ 5% carbohydrate, 20% protein, 70% fat. Participants will receive a daily multi-vitamin, magnesium supplement, and supplemental salt (bouillon cubes) to ascertain micronutrient sufficiency and help with transition to the diet.
- Active Comparator: standard dietThe diet will be consistent with prevailing dietary guidelines and recommendations and contain meat, fish, grains, vegetables, fruit and dairy. At least 50% of grain-based products will be whole grains. Meats will be primarily lean, and dairy products will be fat-free or low-fat. Macronutrient composition will be \~50% carbohydrate (\<10% added sugars), 20% protein, 30% fat. Participants will receive a daily multi-vitamin supplement to ascertain micronutrient sufficiency.
Primary Outcome Measure
Decline in Beta-cell Function [ Time Frame: Change over 1, 5, and 9 months, corrected for baseline ]
Central Contacts
- Belinda Lennerz, MD PhD857-218-3896
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | Belinda Lennerz |
Find similar trials in Boston, MA
Related Studies
- TrialNet Pathway to Prevention of T1DRecruiting · University of South Florida · Orange, California
- The T1D Exchange RegistryRecruiting · T1D Exchange, United States · Boston, Massachusetts
- A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 DiabetesPHASE3 · Recruiting · Vertex Pharmaceuticals Incorporated · Duarte, California
- Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 DiabetesPHASE2 · Recruiting · Massachusetts General Hospital · Charlestown, Massachusetts